EPHEDRINE SULFATE INJECTION USP DIN 00038121
Health Canada record
| Active ingredient(s) | EPHEDRINE SULFATE 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intravenous; Intramuscular |
| Schedule | ETHICAL |
| Class | Human |
| ATC | R03CA02 EPHEDRINE |
| Original market date | 31-Dec-1966 |
| Current status date | 11-Apr-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPHEDRINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00876534 | EPHEDRINE SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | EPHEDRINE SULFATE 50 MG | Marketed |
| 02534282 | EPHEDRINE SULFATE INJECTION USP | EUGIA PHARMA INC. | Solution | EPHEDRINE SULFATE 50 MG | Approved |
| 02529858 | EPHEDRINE SULFATE INJECTION USP | AURO PHARMA INC | Solution | EPHEDRINE SULFATE 50 MG | Approved |
| 02544148 | EPHEDRINE SULFATE INJECTION, USP | BAXTER CORPORATION | Solution | EPHEDRINE SULFATE 50 MG | Approved |
| 02300540 | EPHEDRINE SULFATE INJECTION USP, 50MG/ML | ALVEDA PHARMACEUTICALS INC | Liquid | EPHEDRINE SULFATE 50 MG | Cancelled Pre Market |
| 02242961 | EPHEDRINE SULPHATE INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | EPHEDRINE SULFATE 50 MG | Cancelled Post Market |
| 00540919 | HEMORRO-DOL SUP | PRODUITS FRANCAIS LABS INC. | Suppository | EPHEDRINE SULFATE 2.5 MG; BELLADONNA 11.25 MG; ZINC OXIDE 226.7 MG; BISMUTH SUBNITRATE 37.8 MG; BISMUTH SUBCARBONATE (OXYCARBONATE) 86.4 MG; PERUVIAN BALSAM 22.6 MG; BORIC ACID 226.7 MG; BENZOCAINE 50 MG | Cancelled Post Market |
| 01975471 | SPINAL ANESTHESIA TRAY | BAXTER CORPORATION | Liquid | EPHEDRINE SULFATE 5 %; EPINEPHRINE .1 %; DEXTROSE 10 %; TETRACAINE HYDROCHLORIDE 1 %; LIDOCAINE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 01909509 | SPINAL ANESTHESIA TRAY | BAXTER CORPORATION | Liquid | EPHEDRINE SULFATE 5 %; DEXTROSE 10 %; TETRACAINE HYDROCHLORIDE 1 %; LIDOCAINE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 00457299 | THUNAS PILE SUP | THUNA HERBAL REMEDIES LTD. | Suppository | EPHEDRINE SULFATE 2.5 MG; ZINC OXIDE 225 MG; BENZOCAINE 50 MG; BISMUTH SUBCARBONATE (OXYCARBONATE) 50 MG | Cancelled Post Market |
International API supply for EPHEDRINE SULFATE
7 active FDA Drug Master Files.
Request a quote for EPHEDRINE SULFATE INJECTION USP